A NEW HACE2 TRANSGENIC ANIMAL WITH REMARKABLE PERMISSIVENESS OF LUNG AND CENTRAL NERVOUS SYSTEM TO REPLICATION OF VIRUSES TARGETING HACE2 - AN EXPERIMENTAL MODEL FOR VACCINE, DRUG AND NEURO/IMMUNE/PHYSIO-PATHOLOGY OF COVID-19 AND OTHER PATHOLOGIES LINKED TO VIRUSES OR CORONAVIRUSES USING HACE2 AS A CELLULAR RECEPTOR
MAJLESSI, Laleh, ANNA, François, LANGA VIVES, Francina, CHARNEAU, Pierre, KU, Min-Wen, NOIRAT, Amandine
Year of Publication 30.06.2022
Get full text
Year of Publication 30.06.2022
Patent